Predicting NNRTI resistance - do polymorphisms matter? 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.. 2011.
Prevalence and predictors of protease inhibitor (PI) mutations in HIV-infected UK adults treated with ritonavir-boosted lopinavir as their first PI. 17th Annual Conference of the British HIV Association, 6-8 April 2011.. 2011.
Transmission network parameters estimated from HIV sequences for a nationwide epidemic. J Infect Dis. 204:1463-9.. 2011.
Analysis of the Degree Distribution of HIV Transmission Networks Inferred from Viral Sequence Data. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.. 2010.
Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia. J Infect Dis. 201:1303-7.. 2010.
Bayesian Phylogeography of HIV among MSM in the UK Indicates a Few Source Areas of Widespread Infection. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.. 2010.
The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. AIDS. 24:1917-22.. 2010.
The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. International HIV & Hepatitis Virus Drug Resistance Workshop & Curative Strategies, June 2010.. 2010.
Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UK. AIDS. 24:2397-401.. 2010.
HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom. Antivir Ther. 15:985-91.. 2010.
The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. PLoS One. 5:e9311.. 2010.
The impact of the 0-0 cell on measures of amino acid covariation. AIDS. 24:159-60.. 2010.
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART). J Acquir Immune Defic Syndr. 53:633-9.. 2010.
Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy. Clin Infect Dis. 50:1275-85.. 2010.
Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data. Antivir Ther. 15:203-11.. 2010.
The Prevalence of Darunavir Associated Mutations in PI-naive and PI-experienced HIV-1 Infected Children in the UK. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.. 2010.
The biology, epidemiology and clinical implications of transmitted HIV drug resistant viruses. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.. 2009.
Clustering and Geography: analysis of HIV transmission among UK MSM. 16th International HIV Dynamics & Evolution Meeting, April 2009.. 2009.
Demonstration of sustained drug-resistant HIV-1 lineages circulating among treatment-naïve individuals. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.. 2009.